Recruiting Sarcoma Studies in Kingman
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has ...
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
This phase II trial evaluates the safety and effectiveness of giving immunotherapy (nivolumab and ipilimumab) before surgery for controlling disease in patients with stage I-IIIa sarcomatoid mesotheli...
About Sarcoma Clinical Trials in Kingman
Sarcomas are rare cancers that arise in bone and soft tissues including muscle, fat, blood vessels, and connective tissue. There are more than 70 subtypes of sarcoma. Treatment usually involves surgery combined with radiation and/or chemotherapy.
There are currently 2 sarcoma clinical trials recruiting participants in Kingman, AZ. These studies are seeking a combined 276 participants. Research is being sponsored by Children's Oncology Group, Alliance for Clinical Trials in Oncology. Clinical trial participation is free and participants receive study-related medical care at no cost.
Sarcoma Clinical Trials in Kingman — FAQ
Are there sarcoma clinical trials in Kingman?
Yes, there are 2 sarcoma clinical trials currently recruiting in Kingman, AZ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Kingman?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kingman research site will contact you about next steps.
Are clinical trials in Kingman free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kingman studies also compensate for your time and travel.
What sarcoma treatments are being tested?
The 2 active trials in Kingman are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoma.
Data updated March 2, 2026 from ClinicalTrials.gov